Valuation: Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 7.88B 1.16B 1.02B 953M 875M 1.64B 112B 1.66B 11.32B 4.42B 55.13B 4.37B 4.28B 191B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 5.39B 796M 700M 652M 598M 1.12B 76.36B 1.14B 7.74B 3.02B 37.7B 2.99B 2.92B 130B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day+3.61%
1 week-1.03%
Current month+20.43%
1 month+17.49%
3 months+10.66%
6 months-8.54%
Current year-8.60%
1 week 12.91
Extreme 12.91
13.65
1 month 11.04
Extreme 11.04
14.02
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
17.17
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 44 06/01/2019
Director of Finance/CFO 49 05/12/2021
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 25/03/2014
Director/Board Member 64 25/09/2017
Director/Board Member 44 25/09/2017
Date Insider Type Main position Quantity % Market Cap.
17/07/24 Buy 500 0.0001%
22/01/20 Sell

Director

246,300 0.0462%
01/01/20 Sell 1,095,000 0.2053%
Change 5-day change 1-year change 3-year change Capi.($)
+3.61%-1.03%-15.25%-40.32% 1.12B
+0.24%-0.58%-9.57%-4.79% 13.44B
+1.48%-2.34%-29.89%-50.71% 5.08B
+1.81%+3.33%+1.61%+3.33% 4.8B
+2.07%+1.45%+4.23%-32.06% 4.05B
+1.01%-2.45%+2.41%-8.01% 3.63B
+1.09%+2.67%-0.99%-3.09% 3.63B
+1.02%+3.51%-1.67%+10.63% 3.48B
+3.04%+2.25%-11.86%-22.31% 2.4B
+1.92%-0.31%-3.42%+42.77% 1.82B
Average +1.73%-0.50%-6.44%-10.46% 4.34B
Weighted average by Cap. +1.24%-0.64%-7.09%-10.58%

Financials

2024 2025
Net sales 3.38B 499M 438M 408M 375M 704M 47.82B 713M 4.85B 1.89B 23.61B 1.87B 1.83B 81.62B 2.32B 342M 301M 280M 257M 483M 32.83B 489M 3.33B 1.3B 16.21B 1.28B 1.26B 56.02B
Net income 492M 72.66M 63.88M 59.46M 54.61M 103M 6.97B 104M 707M 276M 3.44B 273M 267M 11.89B -258M -38.07M -33.47M -31.16M -28.61M -53.73M -3.65B -54.44M -370M -145M -1.8B -143M -140M -6.23B
Net Debt -2.29B -338M -297M -277M -254M -477M -32.42B -483M -3.29B -1.28B -16.01B -1.27B -1.24B -55.34B -2.49B -368M -324M -301M -277M -519M -35.29B -526M -3.58B -1.4B -17.43B -1.38B -1.35B -60.23B
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
26/07/26 CN¥13.50 +3.61% 7,192,567
24/07/26 CN¥13.03 -1.96% 4,498,825
23/07/26 CN¥13.29 +0.61% 6,043,590
22/07/26 CN¥13.21 0.00% 9,006,868
21/07/26 CN¥13.21 -3.29% 10,764,056

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock